CROs as a strategic fit – the one stop shop for R&D services
0
SHARES
Posted: 7 April 2008 | V. Sriram, Research Analyst, Frost and Sullivan | No comments yet
Contract Research Organisations (CROs) provide independent development services for pharma, biotechnology, and medical device markets. Services offered by CROs have evolved from providing basic support, to a wide range of services catering to various needs of the market and the sponsors. The United States is the world’s largest market for drugs and accounts for almost half of the research and development (R&D) spending in pharmaceutical and biotechnology markets. Hence, CROs have a strong presence in this market and have invested in new facilities and technologies to cater to a wide range of sponsors. It is estimated that only 25 percent of the R&D activity is currently being outsourced to these organisations. This is likely to double in the coming years due to mounting pressure on the pharmaceutical companies to increase productivity of the cost intensive drug development process.
Contract Research Organisations (CROs) provide independent development services for pharma, biotechnology, and medical device markets. Services offered by CROs have evolved from providing basic support, to a wide range of services catering to various needs of the market and the sponsors. The United States is the world’s largest market for drugs and accounts for almost half of the research and development (R&D) spending in pharmaceutical and biotechnology markets. Hence, CROs have a strong presence in this market and have invested in new facilities and technologies to cater to a wide range of sponsors. It is estimated that only 25 percent of the R&D activity is currently being outsourced to these organisations. This is likely to double in the coming years due to mounting pressure on the pharmaceutical companies to increase productivity of the cost intensive drug development process.
Contract Research Organisations (CROs) provide independent development services for pharma, biotechnology, and medical device markets. Services offered by CROs have evolved from providing basic support, to a wide range of services catering to various needs of the market and the sponsors. The United States is the world’s largest market for drugs and accounts for almost half of the research and development (R&D) spending in pharmaceutical and biotechnology markets. Hence, CROs have a strong presence in this market and have invested in new facilities and technologies to cater to a wide range of sponsors. It is estimated that only 25 percent of the R&D activity is currently being outsourced to these organisations. This is likely to double in the coming years due to mounting pressure on the pharmaceutical companies to increase productivity of the cost intensive drug development process.
In recent years, the portfolio of services offered by CROs has widened dramatically, with many CROs becoming a one stop shop (full service providers) offering an exhaustive list of core and ancillary R&D services. A majority of these overlap on pharmaceutical R&D enabling technologies, using proprietary techniques which include; genomics and proteomics, high throughput screening, combinatorial chemistry and many others. With the high level of merger and acquisition activity in the pharmaceutical industry and with larger companies using greater ‘downsizing’ strategies to concentrate resources on their core competencies, CROs are having to add extra capabilities to their menu of service offerings as a route to sustaining revenue growth. This broadening of CRO services is also leading to an increased availability of expert personnel. With a wider portfolio of services, many CROs now regard themselves as strategic partners of pharmaceutical clients rather than simple service providers or vendors. However, a large proportion of companies continue to view these contractors as specialists in discrete and niche areas.
Biopharmaceutical companies are beginning to turn their focus away from these larger, fullservice providers and are looking at more flexible organisations that can deliver proactive and innovative clinical development and life cycle management solutions on a global basis. As a result, medium-sized global CROs providing access to specialised expertise and expanded patient populations are experiencing significant growth and capturing an increasing market share. There is a definitive increase in the need for CROs to specialise in niche service areas, in addition to the ability and capability of managing complete drug development requirements.
This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.
Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.
What you’ll discover:
Key trends shaping the pharmaceutical formulation sector
Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
As pharmaceutical and biotechnology companies strive to improve their competitiveness, they are taking a long hard look at their outsourcing strategies. Many companies are seeking to reduce the number of global CROs with which they place contracts. They are looking for closer relationships with a smaller number of CROs that have world-class capabilities, competitive pricing and business processes that are compatible with their needs. At the same time, many companies are seeking to outsource a wider range of R&D tasks to CROs both on-shore and off-shore, as a way of reducing fixed operating costs (see Chart 1).
The importance of a strategic partnership is imperative as is evident from the spending as part of total R&D expenditure. The increasing contribution of CRO spending is bound to continue and reach as high as 30 percent by 2013 (see Chart 2).
Given the splurge in the growth of the biotechnology sector, there is automatically a cascading effect on the CRO spending in these areas. Regionally, with increasing outsourcing of the drug development to the Asian countries, the range of services and offerings is only likely to continue. US and Europe garnered an approximate one third market share in revenue terms in 2006.
The first critical step in clinical research outsourcing is to select the right partner. Companies willing to outsource should establish and identify certain criteria important to choosing an outsourcing partner. The potential partner must demonstrate a proven clinical research expertise and companies should evaluate; client lists, the duration of projects, the number of projects, expertise in therapeutic area, quality of the clinical research programmes and the capability of resource allocation, along with cost effectiveness and realistic development time lines. To enable the long-distance monitoring and management of the projects, the potential partners should be able to give a high level of commitment and attention to the client’s need. It is essential to maintain a sustainable balance sheet in the phases (for example, pre-clinical discovery, screening, process development, and the like) prior to having products reaching the market, since the majority of revenues are derived from successful licensing and regulatory approval. The development of patentable products requires healthy investment in R&D and suitable confidentiality of results to develop a strong IP portfolio. To ensure that technology innovation is commercialised to its best potential, companies need to continuously work with domestic government officials and key opinion leaders in establishing and defining standards to comply with regulatory standards. Licensing, outsourcing and research collaboration are the biggest trends at a corporate level in the drug discovery outsourcing industry. Collaborative propositions will be strengthened by strong IP portfolios, broad and versatile product platforms and healthy product pipelines containing therapeutics targeted at a high-growth market. Through collaborations, companies can actively seek to form an industry consortium, work with academic or government institutions and hardware suppliers to establish and define standards. It is recommended that procedures and systems, which meet the principles of good clinical practice for trial management are developed and that these are clearly documented so that adherence is readily demonstrated. For each clinical trial, a risk assessment should generally be undertaken at the protocol development stage. This may be used to plan the details of trial management and to an extent, the monitoring in the trial. These plans should be documented, together with the risk assessment, so that the management strategy is both transparent and justified. The documentation is intended not only to facilitate the management of the trial, but also to help prepare for external audit.
V. Sriram
Research Analyst, Frost and Sullivan
Sriram is a Research Analyst with the European Healthcare Practice at Frost & Sullivan, covering the pharmaceuticals and biotechnology space. He has authored research services on respiratory and oncology markets with a number of articles for Obbec, European Biopharmaceutical Review and Biopharma. He has also been continuously tracking areas including medical devices and clinical diagnostics. His other interests include; security analysis and portfolio management, macroeconomics and marketing.
Prior to joining Frost and Sullivan, Sriram interned at one of the top generic pharmaceutical companies in India where he researched on the bioavailability of Amiodarone Hydrochloride tablets and was responsible for its reformulation and launch.
Sriram has a Bachelor’s degree in Pharmacy from the Birla Institute of Technology and Science, Pilani.
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Cookie
Description
cookielawinfo-checkbox-advertising-targeting
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged
This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.
Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.
Cookie
Description
cf_ob_info
This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob
This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only
This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush
This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db
This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC
This cookie is set by Youtube and is used to track the views of embedded videos.
Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.
Cookie
Description
bcookie
This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS
This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang
This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc
This cookie is set by LinkedIn and used for routing.
lissc
This cookie is set by LinkedIn share Buttons and ad tags.
vuid
We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId
This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule
This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session
This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues
This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga
This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat
This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid
This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.
Cookie
Description
advanced_ads_browser_width
This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions
This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info
This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer
This cookie is set by Advanced Ads and sets the referrer URL.
bscookie
This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE
This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr
This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory
This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE
This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.